EYLEA

EYLEA is an anti–vascular endothelial growth factor.
EYLEA is indicated for the treatment of
- Wet Age-related Macular Degeneration (Wet AMD)
- Diabetic Macular Edema (DME) or Diabetic Retinopathy (DR) in DME
- Macular Edema following Retinal Vein Occlusion (MEfRVO)